Skip to main content

Table 2 Procedural features in patients with FMD <4.2 % and ≥4.2 %

From: Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents

  FMD <4.2 % (n = 40 ) FMD ≥ 4.2 % (n = 40 ) p
Target vessel artery 1.08 ± 0.27 (43 lesions) 1.23 ± 0.53 (49 lesions) 0.12
Left mail trunk, n (%) 3 (7.0) 5 (10.2) 0.46
Left anterior descending, n (%) 12 (27.9) 25 (51.0) <0.01
Left circumflex, n (%) 16 (37.2) 12 (24.5) 0.35
Right coronary disease, n (%) 12 (27.9) 7 (14.3) 0.19
Multivessel coronary disease, n (%) 19 (47.5) 20 (50.0) 0.82
Lesion type B/C2, n (%) 40 (100) 39 (97.5) 0.31
Number of stets per lesion, n (%) 1.3 ± 0.6 1.3 ± 0.7 0.73
Stent diameter (mm) 3.03 ± 0.55 2.85 ± 0.51 0.13
Total stent length (mm) 22.4 ± 14.2 28.3 ± 16.9 0.09
Use of drug eluting stent (%) 27 (67.5) 31 (77.5) 0.32
Stent deployment pressure (atm) 18.3 ± 4.3 18.3 ± 4.5 0.98